What is Reveleer?
Reveleer operates at the intersection of healthcare and artificial intelligence, offering a comprehensive platform designed to facilitate value-based care initiatives. Its AI-driven capabilities integrate critical functions such as retrieval, clinical intelligence, risk adjustment, quality improvement, and member management. This holistic approach empowers healthcare providers and health plans to optimize their workflows, elevate the quality of care delivered, and improve overall performance metrics. By focusing on efficiency and better patient outcomes, Reveleer is positioning itself as a key player in the evolving landscape of healthcare technology, aiming to maximize the value derived from healthcare operations.
How much funding has Reveleer raised?
Reveleer has raised a total of $139.9M across 5 funding rounds:
Series A
$2.5M
Other Financing Round
$1.4M
Series C
$6M
Other Financing Round
$65M
Other Financing Round
$65M
Series A (2013): $2.5M with participation from Upfront Ventures and Redhills Ventures
Other Financing Round (2014): $1.4M led by Upfront Ventures and Redhills Ventures
Series C (2020): $6M supported by Upfront Ventures and Boston Millennia Partners
Other Financing Round (2021): $65M featuring Oak HC/FT
Other Financing Round (2024): $65M backed by Hercules Capital
Key Investors in Reveleer
Upfront Ventures
Upfront Ventures is a Los Angeles-based venture capital firm that invests in technology businesses, with a focus on digital media, SaaS, consumer internet, and retail innovation, supporting startups and emerging companies.
Redhills Ventures
Redhills Ventures is a private family investment firm that focuses on companies with strong business plans and experienced management teams, particularly in high-growth sectors such as healthcare, finance, and technology, engaging in venture capital investments.
Oak HC/FT
Oak HC/FT is a venture growth-equity fund established in 2014, investing in Healthcare Information & Services and Financial Services Technology, providing strategic counsel and access to an extensive network of industry leaders.
What's next for Reveleer?
With the recent major strategic investment, Reveleer is poised for accelerated growth and further development of its AI-powered platform. The substantial capital infusion is expected to fuel expansion into new markets, enhance its technological capabilities, and potentially broaden its service offerings. This strategic backing suggests a focus on scaling operations and solidifying its market position within the competitive healthcare technology sector. The company's continued emphasis on value-based care solutions indicates a forward-looking strategy aimed at addressing the industry's increasing demand for efficiency, improved patient outcomes, and optimized financial performance.
See full Reveleer company page
